A randomized phase II, open-label and multicenter study of combination regimens of bortezomib at two doses by subcutaneous injection for newly diagnosed multiple myeloma patients

Li, Feng; Yao, Fu-Sheng; Zhu, Xi-Jun; Gu, Wei-Ying; Wang, Xiao-Hua; Chen, Bing; Huang, Dong-Ping; Ding, Jia-Hua; Wu, Tian-Qin; Zhu, Yan; Zhao, Qian; Tang, Yu-Mei; Song, Ping; Zhou, Xiao-Gang; An, Zhi-Ming; Guo, Xing; Wang, Xu-Li; Zhong, Long; Xie, Xiao-Bao; Zhai, Yong-Ping

期刊名称Journal of Cancer Research and Clinical Oncology
作者Li, Feng; Yao, Fu-Sheng; Zhu, Xi-Jun; Gu, Wei-Ying; Wang, Xiao-Hua; Chen, Bing; Huang, Dong-Ping; Ding, Jia-Hua; Wu, Tian-Qin; Zhu, Yan; Zhao, Qian; Tang, Yu-Mei; Song, Ping; Zhou, Xiao-Gang; An, Zhi-Ming; Guo, Xing; Wang, Xu-Li; Zhong, Long; Xie, Xiao-Bao; Zhai, Yong-Ping
印刷ISSN0171-5216
电子ISSN1432-1335
文件大小1054.86KB
发表时间2019-7-6
DOI10.1007/s00432-019-02967-3

发现好书期刊，享受阅读乐趣

A randomized phase II, open-label and multicenter study of combination regimens of bortezomib at two doses by subcutaneous injection for newly diagnosed multiple myeloma patients